Patagonia Awarded $1.5MM Grant from the FDA

Thank you FIRST!

FDA Commissioner Gottlieb Outlines Efforts to Advance Biotechnology Innovation

We're headed to Nashville!

Recent Budget Approval Increases Funding Across Nearly All US Science Agencies

Today is Rare Disease Day 2018!

Patagonia Completes Phase 2a Clinical Study for PAT-001

Patagonia Completes Enrollment in Phase IIa Study

Developing Drugs for Rare Diseases: Insights for Pharma Execs

FDA is Advancing the Goals of the Orphan Drug Act